Robert Taylor, DPM
Podiatrist · Frisco, TXNPI 1558433458
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $82,305 of the $99,401 with a category attached, or 82.8%. Treace Medical Concepts, Inc. accounts for 95.2% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2022 at $32,041 and has fallen 99.1% since, to $275 in 2025. Among podiatrist clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 145 payments — averaging $685.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Treace Medical Concepts, Inc.$95K
- Pylant Medical$4K
- Stryker$467
- Amgen$137
- Johnson & Johnson$34
- Smith+Nephew$31
- plus $42 from 2 others
Across 116 payments — averaging $1556.51 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Treace Medical Concepts, Inc.$181K
What the payments were for
- Consulting fees$82,30583%
- Travel & lodging$9,3759%
- Food & beverage$4,1214%
- Education$3,6004%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Treace Medical Concepts, Inc. | 100 | $94,636 |
| Pylant Medical | 9 | $4,053 |
| Stryker(2 entities) | 13 | $467 |
| Amgen | 19 | $137 |
| Johnson & Johnson | 1 | $34 |
| Smith+Nephew | 1 | $31 |
| Averitas Pharma Inc. | 1 | $27 |
| Terumo BCT, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Lapiplasty System$92,640
How this compares
$99,401 in reported general payments places this provider in the 95th percentile of 470 podiatrist providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 131 | $1,046 |
| Celecoxib | 52 | $1,014 |
| Meloxicam | 206 | $563 |
| Terbinafine Hcl | 22 | $331 |
| Ibuprofen | 80 | $315 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 42 | $194 |
| Methylprednisolone | 31 | $167 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 12 | $60 |
Paid to pharmacies, not to this prescriber.
Other podiatrist in Frisco
- Mojgan TavakoliFrisco$79K
- Horst KnappFrisco$15K
- Brian CarpenterFort Worth$1.2M
- Gary LepowHouston$1M
- Wayne HurstCedar Park$625K
- Calvin RushingSunnyvale$452K
- Alan GarrettFort Worth$185K
- Gregory JarygaFt Worth$175K
- Brandon LampeMesquite$154K
- Andrew SchneiderHouston$150K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.